SCHEMBL9314131

SCHEMBL9314131

CC(=O)N[C@H]1C[C@H](O)[C@@H](CO)OC1O

nearest known ligand 0.47

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ OGA O60502 4/20 0.41
▸ MAPK1 P28482 2/20 0.41
▸ ALDH1A1 P00352 2/20 0.36
▸ THRB P10828 1/20 0.36
▸ CD69 Q07108 1/20 0.36
▸ CYP2C19 P33261 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ PYGB P11216 2/20 0.34
▸ GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14669268 1.00 OGA (0.41) OGAMAPK1ALDH1A1THRBCD69
SCHEMBL9314127 1.00 OGA (0.41) OGAMAPK1ALDH1A1THRBCD69
SCHEMBL20812843 1.00 OGA (0.41) OGAMAPK1ALDH1A1THRBCD69
SCHEMBL9314136 1.00 OGA (0.41) OGAMAPK1ALDH1A1THRBCD69
SCHEMBL20193825 0.83 CYP2C9 (0.33) OGAMAPK1ALDH1A1CYP2C19CYP2C9
SCHEMBL9314303 0.81 LGALS8 (0.42) OGAMAPK1ALDH1A1THRBCD69
SCHEMBL9314298 0.81 LGALS8 (0.42) OGAMAPK1ALDH1A1THRBCD69
SCHEMBL9314309 0.81 LGALS8 (0.42) OGAMAPK1ALDH1A1THRBCD69
SCHEMBL24917518 0.79 OGA (0.36) OGAMAPK1ALDH1A1THRBCD69
SCHEMBL18978073 0.79 OGA (0.42) OGALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0527042-A2 3-deoxy-mannosamine derivatives and process for their preparation PHARMACIA S.p.A. (IT) 1993-02-10 — — EP claimed
US-5332756-A Angiogenesis inhibitor, antitumor FARMITALIA CARLO ERBA S.R.L. (IT) 1994-07-26 — — US disclosed
EP-0527042-A2 3-deoxy-mannosamine derivatives and process for their preparation PHARMACIA S.p.A. (IT) 1993-02-10 — — EP disclosed
Send feedback